Apoptosis pathway in colon cancer cell

The "apoptosis pathway in colon cancer cells" refers to the complex network of molecular signals and effectors that control programmed cell death within malignant epithelial cells originating from the colon. These pathways involve numerous genes and proteins—including FAS, TP53 (p53), BAX, TIMP1—and are tightly regulated under physiological conditions. In colorectal carcinogenesis and progression, dysregulation of apoptotic machinery is common; tumor cells often acquire resistance to apoptosis through mutations (such as loss-of-function mutations in TP53), overexpression of anti-apoptotic factors (like BCL2), or alterations in upstream regulatory networks including Wnt/β-catenin and KRAS/MAPK signaling[3][4]. Rather than being a single druggable entity like a receptor or enzyme, the apoptosis pathway encompasses multiple potential therapeutic targets. Drugs may act by restoring pro-apoptotic signals lost during tumorigenesis or inhibiting anti-apoptotic defenses developed by tumor cells. The clinical relevance is underscored by prognostic indices such as the ARGPI—constructed from expression profiles of several key apoptotic genes—which help stratify patients for risk assessment and predict response to chemotherapy[1]. However, because "apoptosis pathway" is not itself a discrete molecule but an aggregate process involving many components with diverse functions across different cellular contexts,[5] it does not fit standard definitions for canonical drug targets. In summary: "Apoptosis pathways in colon cancer cells" describes an essential biological process frequently altered during colorectal carcinogenesis but does not represent a singular molecular target suitable for direct pharmacological intervention without further specification.[3][4]

Other names

Apoptotic signaling pathways in colorectal cancerCell death pathways in colon carcinomaProgrammed cell death mechanisms in colon cancer

Induction or inhibition of programmed cell death via modulation of pro-apoptotic or anti-apoptotic proteins (e.g., BCL2 family, caspases, p53)[3] Activation/inhibition of upstream signaling cascades that regulate apoptosis (e.g., Wnt/β-catenin pathway, KRAS/MAPK pathway)[4]